Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage

No definition available.

Name:	clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage
Namespace Prefix:	clbs_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage

+ References

No definition available.

+ Details

Name:	clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage
Namespace Prefix:	clbs_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Merger Agreement, Transaction Expenses Threshold For Ratio Allocation

+ References

No definition available.

+ Details

Name:	clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation
Namespace Prefix:	clbs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_GrantsReceivable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=clbs_AgreementAndPlanOfMergerAndReorganizationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=clbs_CendTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

The Business (Q1) (Details) - USD ($) $ in Thousands	Apr. 26, 2022	Dec. 31, 2017	Feb. 28, 2017
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Grants awarded			$ 12,200
Subsequent event \| Merger Agreement \| Cend
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Expected post-merger ownership in Company by Cend stockholders (percent)	50.00%
Expected post-merger ownership in Company by Company stockholders (percent)	50.00%
Transaction expenses threshold for allocation	$ 250
CLBS16 Treatment of CMD
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Grants awarded		$ 1,900